NCT03985241

Brief Summary

In patients with chronic stable coronary artery disease (CAD), percutaneous coronary intervention (PCI) targets hemodynamically significant coronary lesions, i.e., those thought to cause inducible ischemia. The hemodynamic severity of a coronary stenosis increases with its tightness and with the myocardial mass of viable myocardium downstream of the stenosis. Compared to the traditional anatomic angiographic approach, assessment of functional relevance by fractional flow reserve (FFR) during coronary angiography has been suggested to improve patient outcomes. Fractional flow reserve (FFR) is based on determination of the coronary perfusion pressure downstream of a stenosis during pharmacologic hyperemia. However, FFR relies on oversimplified physiologic concepts, which limits its usefulness in defining a true ischemic threshold. Furthermore, visual angiographic assessment continues to dominate the treatment decisions for intermediate coronary lesions. Conversely, the intracoronary ECG (icECG) provides an inexpensive, sensitive and direct measure of myocardial ischemia. The icECG is easily acquired by attaching a reusable alligator clamp to a conventional angioplasty guidewire (at one tenth the price of a pressure sensor guidewire). The coronary guide wire positioned downstream of a coronary stenosis then acts as the exploring electrode. During pharmacologic stress, the icECG can provide direct evidence for regional myocardial ischemia to define the ischemic threshold in different types of coronary artery disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P25-P50 for not_applicable coronary-artery-disease

Timeline
Completed

Started Dec 2016

Typical duration for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 3, 2016

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

June 5, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 13, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2019

Completed
Last Updated

December 19, 2019

Status Verified

December 1, 2019

Enrollment Period

3 years

First QC Date

June 5, 2019

Last Update Submit

December 18, 2019

Conditions

Keywords

Intracoronary ElectrocardiogramFractional Flow ReserveCollateral Flow IndexDobutamine

Outcome Measures

Primary Outcomes (1)

  • Intracoronary Electrocardiogram ST-Segment Shift

    Change in intracoronary ST-segment shift from baseline to hyperemia, measured at the J-Point in mV

    Measured at maximal heart frequency (=~6min after begin dobutamine)

Secondary Outcomes (4)

  • Percent Diameter Stenosis

    During diagnostic angiography at the beginning of the coronary angiography

  • Fractional Flow Reserve

    Measured at maximal heart frequency (=~6min after begin dobutamine)

  • Instantaneous wave-free ratio

    Measured at baseline before inotropic stress

  • Area at Risk

    Measured after the coronary angiography, expected to be on average after 3 days

Study Arms (1)

Functional Assessment of Myocardial Ischemia by icECG

EXPERIMENTAL

Evaluation of ST-Shifts in the icECG acquired downstream of a coronary lesion during pharmacologic inotropic stress using dobutamine (40mcg/kg/min).

Diagnostic Test: Functional Assessment of Myocardial Ischemia by icECG

Interventions

Functional Assessment of Myocardial Ischemia by icECG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • Referred for elective coronary angiography
  • Written informed consent to participate in the study

You may not qualify if:

  • Acute coronary syndrome
  • Severe aortic stenosis
  • Acute congestive heart failure NYHA III-IV
  • Prior myocardial infarction in the vascular territory undergoing pressure measurements
  • Presence of left bundle branch block, non-sinus rhythm or paced rhythm in resting ECG
  • Coronary anatomy unsuitable for coronary pressure measurements
  • Severe pulmonary, renal or hepatic disease
  • Contraindication to inotropic stress
  • Women of childbearing age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Inselspital, Bern

Bern, Switzerland

Location

Related Links

MeSH Terms

Conditions

Coronary Artery DiseaseAngina, StableCoronary StenosisIschemia

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesAngina PectorisChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Christian Seiler, MD, Prof

    Inselspital, Bern University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2019

First Posted

June 13, 2019

Study Start

December 3, 2016

Primary Completion

December 13, 2019

Study Completion

December 13, 2019

Last Updated

December 19, 2019

Record last verified: 2019-12

Locations